We are live on ! Find out more
OLA

Oliver Luxxe Assets Portfolio holdings

AUM $680M
1-Year Est. Return 47.51%
This Fund
S&P 500
This Quarter Est. Return
+0.23%
1 Year Est. Return
+47.51%
3 Year Est. Return
+141.35%
5 Year Est. Return
+220.75%
10 Year Est. Return
+625.72%
AUM
$395M
AUM Growth
+$211K
Cap. Flow
+$9.86M
Cap. Flow %
2.5%
Top 10 Hldgs %
21.55%
Holding
226
New
31
Increased
81
Reduced
53
Closed
36

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$4.63M
2
LRCX icon
Lam Research
LRCX
+$3.63M
3
BX icon
Blackstone
BX
+$3.35M
4
TJX icon
TJX Companies
TJX
+$3.3M
5
TEL icon
TE Connectivity
TEL
+$3.19M

Sector Composition

Rank Sector Weight
1 Industrials 16.84%
2 Financials 13.99%
3 Healthcare 12.69%
4 Energy 9.97%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PM icon
26
Philip Morris
PM
$297B
$4.42M 1.12%
47,073
-1,191
-2% -$119K
ACN icon
27
Accenture
ACN
$102B
$4.38M 1.11%
12,998
+3,841
+42% +$1.3M
WFC icon
28
Wells Fargo
WFC
$261B
$4.37M 1.11%
90,177
+447
+0.5% +$23.9K
VGT icon
29
Vanguard Information Technology ETF
VGT
$139B
$4.21M 1.07%
80,896
-7,072
-8% -$363K
ALLY icon
30
Ally Financial
ALLY
$13.2B
$4.18M 1.06%
96,228
+2,135
+2% +$101K
LKQ icon
31
LKQ Corp
LKQ
$5.72B
$4.1M 1.04%
90,264
+4,312
+5% +$221K
SNA icon
32
Snap-on
SNA
$21.2B
$4.1M 1.04%
19,935
-337
-2% -$71.1K
WBA
33
DELISTED
Walgreens Boots Alliance
WBA
$3.91M 0.99%
+87,388
New +$4.3M
IRM icon
34
Iron Mountain
IRM
$36.4B
$3.73M 0.94%
67,233
-1,090
-2% -$51.9K
PERI icon
35
Perion Network
PERI
$375M
$3.63M 0.92%
161,489
+51,282
+47% +$1.09M
LYB icon
36
LyondellBasell Industries
LYB
$20B
$3.63M 0.92%
35,295
-826
-2% -$82.3K
V icon
37
Visa
V
$684B
$3.62M 0.91%
16,301
-43
-0.3% -$9.3K
COST icon
38
Costco
COST
$422B
$3.61M 0.91%
+6,264
New +$3.29M
BAC icon
39
Bank of America
BAC
$435B
$3.56M 0.9%
86,301
-722
-0.8% -$32.6K
TGT icon
40
Target
TGT
$65.6B
$3.45M 0.87%
16,238
-5,018
-24% -$1.09M
CSCO icon
41
Cisco
CSCO
$457B
$3.42M 0.87%
61,375
+325
+0.5% +$18.4K
RTX icon
42
RTX Corp
RTX
$290B
$3.38M 0.86%
34,117
-1,121
-3% -$106K
MDLZ icon
43
Mondelez International
MDLZ
$79.5B
$3.34M 0.85%
53,265
+324
+0.6% +$21.1K
BSCO
44
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$3.32M 0.84%
157,376
-8,320
-5% -$178K
AXP icon
45
American Express
AXP
$227B
$3.31M 0.84%
17,703
+15,662
+767% +$2.83M
HCA icon
46
HCA Healthcare
HCA
$87.2B
$3.31M 0.84%
13,190
-280
-2% -$70.3K
ASO icon
47
Academy Sports + Outdoors
ASO
$2.94B
$3.21M 0.81%
81,377
+30,450
+60% +$1.12M
NXST icon
48
Nexstar Media Group
NXST
$5.82B
$3.04M 0.77%
16,112
+485
+3% +$84.3K
WCC
49
WESCO International
WCC
$16.7B
$2.98M 0.75%
22,913
+1,238
+6% +$155K
ELV icon
50
Elevance Health
ELV
$81.5B
$2.92M 0.74%
+5,936
New +$2.71M

Similar funds

Oliver Luxxe Assets's Q1 2022 Portfolio in Review

As of Q1 2022, Oliver Luxxe Assets held 226 positions worth $395M, up 0.05% from $395M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Oliver Luxxe Assets's Q1 2022 filing shows 31 new, 81 increased, 53 reduced and 36 closed positions. Its largest new stake was Baker Hughes: 187,612 shares worth $6.83M. The largest sale was Regeneron Pharmaceuticals, an estimated $4.63M.

By sector, the portfolio is most concentrated in Industrials at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

  • Oliver Luxxe Assets's largest Q1 2022 buy was Baker Hughes: 187,612 shares worth $6.83M.
  • Oliver Luxxe Assets added most to Procter & Gamble in Q1 2022, an estimated $4.59M increase.
  • Oliver Luxxe Assets's biggest Q1 2022 reduction was iShares Core S&P Small-Cap ETF, cutting an estimated $2.03M.
  • Oliver Luxxe Assets fully exited Regeneron Pharmaceuticals in Q1 2022, selling an estimated $4.63M.
  • Oliver Luxxe Assets's ten largest holdings make up 22% of its $395M portfolio in Q1 2022.
  • Oliver Luxxe Assets opened 31 new positions and closed 36 in Q1 2022.
  • Oliver Luxxe Assets's portfolio value rose 0.05% quarter-over-quarter to $395M.

Based on Oliver Luxxe Assets's 13F filing for Q1 2022, filed 13 May 2022.